Skip to content

4885.T

MUROMACHI CHEMICALS INC.

スタンダード · 医薬品 · 医薬品 · JP

JPY 904.00
+0.22%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue7.4B6.7B6.4B6.3B5.7B
Cost of Revenue1.3B4.7B4.5B4.5B3.9B
Gross Profit490.9M2.0B1.9B1.8B1.7B
Operating Expenses
R&D Expense
SG&A Expense416.3M1.5B1.4B1.4B1.3B
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses416.3M1.5B1.4B1.4B1.3B
Cost and Expenses6.7B6.2B5.9B5.9B5.2B
Operating Income (EBIT)627.0M432.0M421.0M369.0M437.0M
Non-Operating
Interest Income2.1M2.3M2.1M38.0K4.0K
Interest Expense11.9M29.0M18.5M17.7M17.0M
Net Interest Income(9.8M)(26.7M)(16.3M)(17.7M)(17.0M)
Other Non-Op Income/Expense(1.7M)(2.1M)6.3M(18.5M)(14.3M)
Non-Operating Income (excl Interest)8.3M27.8M24.1M12.8M10.4M
EBT (Pre-Tax Income)73.0M350.0M468.6M350.9M425.6M
Income Tax Expense15.5M108.8M138.4M94.6M(30.7M)
Bottom Line
Net Income365.0M241.0M330.0M256.0M456.0M
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income365.0M241.0M330.0M256.0M456.0M
Per Share
Basic EPS¥91¥60¥83¥68¥124
Diluted EPS¥91¥59¥82¥64¥113
Revenue Per Share¥1,838¥1,666¥1,609¥1,668¥1,541
Shares
Basic Shares Outstanding4.0M4.0M4.0M3.8M3.7M
Diluted Shares Outstanding
Profitability Metrics
EBITDA593.7M557.2M491.3M538.2M
D&A161.7M136.2M122.3M101.2M
EBIT627.0M432.0M421.0M369.0M437.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Feb 1, 2026